• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

2

CATEGORIES

  • 2

PRICE

0
0
2
2

PUBLISHED

0
0
0
2

PRODUCT TYPE

2

Search "Orphan Drugs in Europe: Pricing, Reimbursement, Funding and Market Access Issues, 2011 Edition" returned 2 results.

PRODUCT TITLE
Orphan Drugs in Europe: Pricing, Reimbursement, Funding and Market Access Issues, 2011 Edition Orphan Drugs in Europe: Pricing, Reimbursement, Funding and Market Access Issues, 2011 Edition - Product Thumbnail Image Special Offer Sale Banner

Orphan Drugs in Europe: Pricing, Reimbursement, Funding and Market Access Issues, 2011 Edition

The cost of treating rare disease in an age when austerity measures are hitting total healthcare funding across Europe is a highly controversial, even emotive subject There is a clear and pressing clinical...

June 2011
FROM
Orphan Drugs in Europe: Pricing, Reimbursement, Funding & Market Access Issues, 2013 Edition Orphan Drugs in Europe: Pricing, Reimbursement, Funding & Market Access Issues, 2013 Edition - Product Thumbnail Image Special Offer Sale Banner

Orphan Drugs in Europe: Pricing, Reimbursement, Funding & Market Access Issues, 2013 Edition

The cost of treating rare disease in an age when austerity measures are hitting total healthcare funding across Europe is a highly controversial, even emotive subject. There is a clear and pressing...

October 2013
Loading Indicator

Our Clients

NBC Universal Inc. Samsung Group Ltd. E.ON SE DHL International GmbH University of Cambridge Kone Oyj BP Plc.